madman
Super Moderator
* This clinical blog covers the essential testing trio—aldosterone, renin, and potassium—and explains why clinicians can confidently test patients without halting their current blood pressure medications.
Mastering the clinical approach to primary aldosteronism is critical for identifying a major underlying cause of essential hypertension. Matthew F. Watto, MD and Paul N. Williams, MD share key insights from world expert Anand Vaidya, MD, detailing why this condition is severely under-screened despite affecting up to 25% of patients with essential hypertension.
This clinical blog covers the essential testing trio—aldosterone, renin, and potassium—and explains why clinicians can confidently test patients without halting their current blood pressure medications. Learn why eplerenone is favored over spironolactone for male patients due to side effect profiles, and explore upcoming medical breakthroughs like aldosterone synthase inhibitors alongside less invasive micro-foci imaging modalities.
Chapters
00:00 - Introduction to Primary Aldosteronism
00:43 - Evolutionary Context: Sodium vs. Potassium Diets
01:30 - The Current Under-Screening Crisis in Primary Care
02:08 - The Three Core Lab Tests for Screening
02:32 - Navigating Clinical Dilemmas & Medication Management
03:54 - Medical Management: Eplerenone vs. Spironolactone
05:04 - Future Outlook: Aldosterone Synthase Inhibitors & Advanced Imaging
Mastering the clinical approach to primary aldosteronism is critical for identifying a major underlying cause of essential hypertension. Matthew F. Watto, MD and Paul N. Williams, MD share key insights from world expert Anand Vaidya, MD, detailing why this condition is severely under-screened despite affecting up to 25% of patients with essential hypertension.
This clinical blog covers the essential testing trio—aldosterone, renin, and potassium—and explains why clinicians can confidently test patients without halting their current blood pressure medications. Learn why eplerenone is favored over spironolactone for male patients due to side effect profiles, and explore upcoming medical breakthroughs like aldosterone synthase inhibitors alongside less invasive micro-foci imaging modalities.
Chapters
00:00 - Introduction to Primary Aldosteronism
00:43 - Evolutionary Context: Sodium vs. Potassium Diets
01:30 - The Current Under-Screening Crisis in Primary Care
02:08 - The Three Core Lab Tests for Screening
02:32 - Navigating Clinical Dilemmas & Medication Management
03:54 - Medical Management: Eplerenone vs. Spironolactone
05:04 - Future Outlook: Aldosterone Synthase Inhibitors & Advanced Imaging